SENORES PHARMACEUTICALS L Financial Flexibility Index
SENORES PHARMACEUTICALS L financial flexibility index. SENORES PHARMACEUTICALS L (SENORES) has a Financial Flexibility Index of 0.27x as of September 2025. Free cash flow of Rs1.21 Billion (operating CF Rs242.20 Million minus capex Rs966.90 Million) represents 0% of total liabilities (Rs4.54 Billion). See SENORES FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of SENORES PHARMACEUTICALS L (2022–2026)
Financial flexibility index of SENORES PHARMACEUTICALS L from 2022 to 2026. Historical Financial Flexibility Index trend for SENORES PHARMACEUTICALS L across 5 annual periods. Check SENORES PHARMACEUTICALS L cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
SENORES PHARMACEUTICALS L Financial Flexibility Index by Year (2022–2026)
SENORES PHARMACEUTICALS L financial flexibility index by year from 2022 to 2026. Year-by-year free cash flow to debt coverage for SENORES PHARMACEUTICALS L. For the full cash flow conversion analysis, see SENORES cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.51x | Rs3.27 Billion | Rs620.50 Million | Rs6.39 Billion | ▼ -97.7% |
| 2025 | 22.01x | Rs1.12 Billion | Rs-459.20 Million | Rs50.70 Million | ▲ +32767.4% |
| 2024 | 0.07x | Rs261.30 Million | Rs-257.00 Million | Rs3.90 Billion | ▼ -87.6% |
| 2023 | 0.54x | Rs461.98 Million | Rs-10.79 Million | Rs855.54 Million | ▲ +5084.3% |
| 2022 | 0.01x | Rs2.35 Million | Rs-104.47 Million | Rs225.62 Million | — |